Protease inhibitor-sparing regimens: new evidence strengthens position.

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Protease inhibitor-sparing regimens: new evidence strengthens position.

Journal of acquired immune deficiency syndromes (1999) - 1 Jun 2003

Moyle Graeme J

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alkynes
Share to Benzoxazines
Share to Clinical Protocols
Share to Cyclopropanes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Protease Inhibitors

Share to Immunosuppression Therapy

Share to Nevirapine

Share to Oxazines

Source

Open in PubMed

Identifiers

PMID: 12946062

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Protease inhibitor-sparing regimens: new evidence strengthens position.PMID 12946062Read ↗

Protease inhibitors: Role and potential therapeutic use in human cancerSemantic proximity Read ↗

[Resistance to protease inhibitors: the burden of mutations].Semantic proximity Read ↗

Recent developments in HIV protease inhibitor therapy.Semantic proximity Read ↗

Current and Novel Inhibitors of HIV ProteaseSemantic proximity Read ↗

Anti-HIV agents. Monotherapy studies--points to consider.Semantic proximity Read ↗

An update on PARP inhibitors—moving to the adjuvant settingSemantic proximity Read ↗

[Resistance to protease inhibitors].Semantic proximity Read ↗

New antiretroviral drugs part I: PIs.Semantic proximity Read ↗

More clinical data on protease inhibitors.Semantic proximity Read ↗

Incorporation of crizotinib into the NCCN guidelines.Semantic proximity Read ↗

HIV protease mutations leading to reduced inhibitor susceptibility.Semantic proximity Read ↗

[Alpha-1 proteinase inhibitor substitution: when and how?].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.